Eli Lilly and Co. (NYSE:LLY) is one of the best beginner stocks to buy, according to analysts. On September 17, the company announced that its diabetes medication, Mounjaro, delivered positive results in Phase 3 Trials in children and adolescents with type 2 diabetes. Eli Lilly and Company (LLY) Diabetes Medication Successful in Children and Adolescents The diabetes medication reportedly demonstrated significant improvements in blood sugar control and body mass index. The Phase 3 SURPASS-PEDS trial met i ...

Microsoft Corporation (NASDAQ:MSFT) is one of the best beginner stocks to buy, according to analysts. On September 16, the company confirmed that its Digital Crimes Unit had successfully brought the Raccoon365 phishing network under control. Cybercriminals have used the tool to steal Microsoft 365 usernames and passwords. Microsoft Corporation (MSFT) Takes Down Raccoonn365 Phishing Network Ken Wolter / Shutterstock.com With the help of a court order, the unit seized 338 websites associated with Raccoon3 ...

Group 1 - Novo Nordisk has been upgraded from 'Hold' to 'Buy' by Berenberg, with a revised price target of DKK425.00, indicating a potential 20% upside [1][2] - The upgrade follows a series of guidance downgrades after the company's mid-2024 share price peak, leading to a reset in market expectations [2] - Berenberg believes the shift in expectations allows for a more positive discussion regarding Novo Nordisk's growth prospects, valuation, and strategic catalysts, particularly in diabetes and obesity treatments [2][3] Group 2 - Berenberg has changed its sector preference, favoring Novo Nordisk over competitor Eli Lilly, citing Novo's potential for renewed momentum under new leadership [3] - Despite existing challenges, Berenberg sees opportunities for positive surprises and strategic wins that could enhance Novo Nordisk's position in the obesity drug market [3] - Novo Nordisk specializes in developing innovative medicines and delivery systems for chronic diseases, primarily focusing on diabetes, obesity, and rare blood and endocrine disorders [4]

Group 1 - Boston Scientific Corporation (BSX) is viewed positively by analysts, with a 'Buy' rating and a price target of $121, as the company prepares to launch its Bolt laser-based intravascular lithotripsy (IVL) system for peripheral use in late 2025 [1][2] - The company is currently enrolling participants for a fracture study to assess the clinical application of the IVL technology, targeting an $8.5 billion market opportunity [2][3] - The Bolt system is expected to outperform Shockwave Medical's IVL system in terms of deliverability, pulse count, and reliability, which should facilitate rapid market share acquisition in the IVL segment [3] Group 2 - The IVL technology is projected to contribute an additional 0.3% to Boston Scientific's revenue growth and 0.5% to earnings per share (EPS) growth over the next five years [3] - Boston Scientific is a global medical technology company focused on developing and selling less-invasive medical devices aimed at improving patient outcomes and reducing healthcare costs [4]

AUSTIN, Texas--(BUSINESS WIRE)--Fal.Con 2025, Las Vegas – CrowdStrike (NASDAQ: CRWD) today announced new Falcon® Data Protection innovations that deliver real-time, unified security built for how data moves in the AI era. By addressing the rising risks of GenAI data leaks, insider threats, and sensitive data in motion across hybrid environments, CrowdStrike is defining the future of data protection and driving consolidation of legacy, fragmented tools at scale. "AI has reshaped how data is crea. ...

SAN DIEGO , Sept. 18, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that the Charter Communications class action lawsuit – captioned Sandoval v. ...

You can find original article here Wealthmanagement. Subscribe to our free daily Wealthmanagement newsletter. Ascensus, a tax-advantaged retirement and education savings provider, has added a role to bolster connections between wealth and asset managers and its 16 million account holders and roughly $862 billion in assets under administration. Ascensus has hired Josh Rundle from Transamerica to head up investment and wealth solutions. Rundle will start later this month and report to Ascensus CEO David ...

Group 1 - Intuit is focusing on AI-driven solutions and expanding into the mid-market segment, as reiterated by CFO Sandeep Aujla at the Goldman Sachs Communicopia + Technology Conference 2025 [1][2] - The company aims to scale its customer base to exceed 100 million globally, targeting the $89 billion opportunities surrounding AI [3] - Intuit's strategy includes enhancing customer experiences and developer productivity through AI, with 80% of developers using AI tools that improve coding productivity by 40% [2][4] Group 2 - The introduction of AI agents has already resulted in customers saving an average of 12 hours per month [4] - Intuit is a global financial technology company known for products like QuickBooks, TurboTax, Credit Karma, and Mailchimp [5]

SAP SE (NYSE:SAP) is one of the best beginner stocks to buy, according to analysts. On September 11, the company completed the acquisition of SmartRecruiters. With the acquisition, it gains access to enterprise-grade talent acquisition software. SAP SE (SAP) Completes SmartRecruiters Acquisition The company plans to integrate the software into the SAP SuccessFactors Human Capital Management (HCM) suite. The integration should make it easier for enterprises to manage the hiring lifecycle from sourcing to ...

Group 1 - Intuitive Surgical, Inc. (NASDAQ:ISRG) is considered one of the best beginner stocks to buy, with an 'Outperform' rating and a price target of $685 from Bernstein SocGen Group [1][2] - The stock is currently trading at a discount after a pullback from its high of $610 per share in January, presenting a buying opportunity for investors in the medical technology sector [2][3] - The company is set to launch five transformational products, which are expected to enhance its long-term prospects and strengthen market sentiment [3] Group 2 - Intuitive Surgical develops and markets the da Vinci robotic-assisted surgical system, aimed at making surgeries more effective and less invasive for patients [4] - The company reported a 21% year-over-year increase in second-quarter revenue, reaching $2.44 billion, driven by the broad launch phase of the da Vinci 5 surgical system [3]